EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HBV Envelope Protein-Bearing Vesicles Show Preferential Uptake in Hepatocyte-Derived Cells

Eri Takayama, Misaki Enomoto, Manami Nagae, Momoko Tomoda, Yuta Miyazumi, Yuki Iwaisako iD, Ryota Shirasawa, Youichi Suzuki iD, Takashi Nakano, Keiji Ueda, Masahiro Fujimuro iD

International Journal of Molecular Sciences · 13.05.2026 · 27 (10) · 4331

DOI: 10.3390/ijms27104331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.05.2026. Verfasst von Eri Takayama und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Kyoto Pharmaceutical University, Kyoto 607-8412, Japan. Hauptthemen laut MEDLINE: Hepatocytes, Hepatitis B virus, Viral Envelope Proteins, Secretory Vesicles. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: TERUMO Life Science Foundation, Smoking Research Foundation, The Science Research Promotion Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Controlled delivery using nanoparticle-based systems has attracted considerable attention; however, achieving cell-type specificity remains a major challenge. To address this issue, we focused on the intrinsic cell tropism of viruses. The hepatocyte tropism of hepatitis B virus (HBV) is mediated by interactions between its large envelope protein (L protein) and host factors, including the sodium taurocholate cotransporting polypeptide (NTCP). In this study, we explored viral-like secretory vesicles (VLSVs) displaying HBV spike proteins as a virus-inspired vesicle platform for hepatocyte targeting. We previously established a method for producing VLSVs from HBV L- and S-expressing HEK293T cells. In the present study, we developed an improved protocol using exosome-depleted fetal calf serum and optimized ultracentrifugation, resulting in VLSVs with comparable particle numbers and sizes but approximately tenfold higher protein content per particle. VLSVs were concentrated using a two-layer sucrose cushion, labeled with DiI, and purified by sucrose density gradient ultracentrifugation. We evaluated DiI uptake in hepatocyte-derived cells (HepG2 and Huh7), non-hepatic cells (MDA-MB231, H1299, HeLa, and Vero), and NTCP-overexpressing HepG2 cells. VLSVs showed preferential uptake in the following order: NTCP-overexpressing HepG2 > HepG2 > Huh7 > non-hepatic cells. Furthermore, removal of the N-terminal Flag tag from the L protein enhanced hepatocyte-associated uptake, suggesting the importance of preserving the native structure of the preS1 domain. While vesicle characterization and mechanistic validation remain to be further investigated, these findings provide a proof-of-concept for a virus-inspired vesicle platform exhibiting preferential uptake in hepatocyte-derived cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatocytesHepatitis B virusViral Envelope ProteinsSecretory VesiclesHumansAnimalsHep G2 CellsHEK293 CellsSymportersOrganic Anion Transporters, Sodium-Dependent

Stichwörter der Autor:innen

HBVNTCPdrug deliveryhepatocytenanocarriersecretory vesicleviral-like secretory vesiclevirus-like particle

Substanzen

Viral Envelope ProteinsSymporterssodium-bile acid cotransporterL protein, hepatitis B virusOrganic Anion Transporters, Sodium-Dependent

Autor:innen und Institutionen

  • Department of Cell Biology, Kyoto Pharmaceutical University, Kyoto 607-8412, Japan.
  • Analytical Technology Division, HORIBA Techno Service Co., Ltd., Kyoto 601-8305, Japan.
  • Department of Microbiology and Infection Control, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
  • Laboratory of Biosafety Research, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Osaka 569-8686, Japan.
  • Division of Virology, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.

ORCID-Profile: Yuki Iwaisako, Youichi Suzuki, Masahiro Fujimuro

Förderung

  • TERUMO Life Science Foundation
  • Smoking Research Foundation
  • The Science Research Promotion Fund

Zitieren

APA

Takayama, E., Enomoto, M., Nagae, M., Tomoda, M., Miyazumi, Y., Iwaisako, Y., Shirasawa, R., Suzuki, Y., Nakano, T., Ueda, K., & Fujimuro, M. (2026). HBV Envelope Protein-Bearing Vesicles Show Preferential Uptake in Hepatocyte-Derived Cells. International Journal of Molecular Sciences, 27(10), 4331. https://doi.org/10.3390/ijms27104331

Vancouver

Takayama E, Enomoto M, Nagae M, Tomoda M, Miyazumi Y, Iwaisako Y, et al. HBV Envelope Protein-Bearing Vesicles Show Preferential Uptake in Hepatocyte-Derived Cells. International Journal of Molecular Sciences. 2026;27(10):4331. doi:10.3390/ijms27104331

BibTeX
@article{Takayama2026,
  author = {Takayama, Eri and Enomoto, Misaki and Nagae, Manami and Tomoda, Momoko and Miyazumi, Yuta and Iwaisako, Yuki and Shirasawa, Ryota and Suzuki, Youichi and Nakano, Takashi and Ueda, Keiji and Fujimuro, Masahiro},
  title = {HBV Envelope Protein-Bearing Vesicles Show Preferential Uptake in Hepatocyte-Derived Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {10},
  pages = {4331},
  doi = {10.3390/ijms27104331}
}
Kostenlos starten →